Journal of the American Academy of Dermatology · 2019
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alikhan Ali, Sayed Christopher, Alavi Afsaneh, Alhusayen Raed, Brassard Alain, Burkhart Craig, Crowell Karen, Eisen Daniel B, Gottlieb Alice B, Hamzavi Iltefat, Hazen Paul G, Jaleel Tara, Kimball Alexa B, Kirby Joslyn, Lowes Michelle A, Micheletti Robert, Miller Angela, Naik Haley B, Orgill Dennis, Poulin Yves
Аннотация
Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.
Предметные рубрики MeSH
Anti-Bacterial AgentsBiological ProductsCanadaComplementary TherapiesDermatologic Surgical ProceduresDrug Therapy, CombinationEvidence-Based MedicineFemaleHidradenitis SuppurativaHumansImmunosuppressive AgentsMaleNorth AmericaPractice Guidelines as TopicPublishingRisk AssessmentSeverity of Illness IndexUnited States